CD274 and neoplasm: The rationale behind this combination is that blockage of the PD-1/PD-L1 pathway does not necessarily lead to antitumor immunity, if PD-1+ CTLs are not present in the tumor.34Furthermore, in case they are present, their actions might be counteracted by immunosuppressive T cells such as Treg.